Since more than 15 years we are developing and manufacturing retroviral vectors for clinical supply. Check out what we can do for you.
EUFETS supports you in the development and industrialization of your cell-based therapy product: fast, safe and efficient.
We manufacture GMP grade IVT mRNA that can be used either as a drug product for in vivo use or as starting material for ex vivo applications.
Explore how we ensure that your technology is transferred in an efficient and timely manner and with a particular attention to quality.
Process development for innovative new drugs is a complex task, requiring customized solutions for each product.
Our experienced analytical team offers customized assay development based on cell biology, virology, molecular biology, and microbiology technologies.
We have established robust GMP manufacturing processes for a variety of different retroviral vectors, cells and mRNA products. Learn more about our clinical and commercial supply capabilities.
Our QC team ensures quality, safety and batch-to-batch consistency of all manufactured products. We have established more than 50 assays for the characterization of our customers' products.
Learn how our QA team provides directions throughout each customer project to ensure quality and regulatory compliance of all products.
Welcome to the new EUFETS website - we hope you like it! It will give our customers and future customers a good overview of all EUFETS has to offer....
January 17, 2017
The downstream processing of viral vector particles for gene therapy is becoming a critical bottleneck as upstream titers keep improving. Moreover,...
December 01, 2016
Per November 1, 2016, Stephan Müller starts as member of the management team of EUFETS. He is responsible for overall day-to-day administration and...
November 01, 2016
EUFETS will be sponsor and exhibitor of the 25th Anniversary Congress of the ESGCT that will take place in collaboration with the German Society for...